Hurlow Wealth Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Hurlow Wealth Management Group's PFE Position: Q1 2025 in Review
Hurlow Wealth Management Group sold out of Pfizer (PFE) in Q1 2025, closing a stake of 7,616 shares — an estimated $202K sold.
Hurlow Wealth Management Group first reported a position in PFE in Q4 2018 and held it in 25 quarters. The position peaked at $1.02M in Q4 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Hurlow Wealth Management Group reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Hurlow Wealth Management Group sold 7,616 Pfizer shares in Q1 2025, an estimated $202K.
- Hurlow Wealth Management Group first reported a position in Pfizer in Q4 2018 and held it in 25 quarters.
- Hurlow Wealth Management Group's Pfizer position peaked at $1.02M in Q4 2022.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Hurlow Wealth Management Group's 13F filing for Q1 2025, filed 8 May 2025.